We are open minded and we support different types of OEM and co-development.

If you have an assay already and you would like to fit in into a sample to result system, or if you have a project that you would like to build around our cartridge system. We could explore the collaboration.

We are an international company

We have Europe office in Sweden for the Sales and technical support. We have 1400㎡ GMP factory and 800㎡ R&D center in Asia. We have more than 50 employees in global.

Skilled in operation, but unable to understand the mechanism? These key points of nucleic acid detection need to be mastered!

With the implementation of strict control measures, the rampant epidemic of COVID-19 has been effectively curbed, and we have a gap for adjustment. In the process of nucleic acid batch screening, many colleagues are skilled in operation, but the mechanism is not very clear. Based on this, we have summarized the contents that may be involved in the detection of COVID-19 nucleic acid, with a view to helping the majority of colleagues to "know what is going on and why".

Science: Major breakthrough! The copyright of the one-time multiple nucleic acid detection platform developed by Zhang Feng's team based on CRISPR belongs to the author.

In a new study, a rapid and cheap highly sensitive CRISPR based diagnostic tool - SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCK) was developed for the first time. The researchers greatly enhanced the function of this tool and developed a micro strip test method, which allows the naked eye to observe the test results without using expensive equipment. Relevant research results were published online in Science on February 15, 2018, with the title of "Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6".

Where are the investment opportunities behind nucleic acid testing?

If the genetic material of the virus, nucleic acid, can be found in the human body, it is undoubtedly the conclusive evidence that the person is infected. Since the outbreak of COVID-19 pneumonia, nucleic acid detection kits have replaced traditional medical images and become the final barrier between confirmed patients and suspected patients.

When multiple pathogens strike, are you still 1+1+1+1? The fast detection method is here!

The cold dew has passed, the temperature has dropped significantly in recent days, and the annual flu has also hit again. In the face of this familiar and unfamiliar "friend", how we prevent and control respiratory infectious diseases represented by COVID-19 and influenza is a threat that the world faces in recent years.

Increase R&D investment, BGI supports accurate nucleic acid detection in multiple dimensions

Since the outbreak of COVID-19, China has effectively controlled the virus with strong technology, and formulated relevant management policies in time, so that people's lives can quickly return to normal.

What are the clinical and patient needs?

On November 5, 021, sponsored by the Pediatric Branch of Chinese Medical Association and the National Clinical Medical Research Center for Respiratory Diseases, edited by Professor Xu Baoping, and co compiled by 30 domestic experts in various fields of pediatric respiratory, infectious and laboratory medicine, the popular science picture book of children's respiratory tract pathogens, Uncovering the "Troublers" in the Respiratory Tract, published by the People's Health Publishing House, was officially released at the Great Wall Pediatrics Forum in Beijing.

What kind of children are suitable for multiple nucleic acid testing?

The consensus points out that: "For patients with emergency indications and those who are hospitalized due to acute respiratory infectious diseases or who have new respiratory infection symptoms (with or without fever) during hospitalization In case of respiratory distress of unknown cause, acute deterioration of chronic heart and lung disease, neutropenia/deficiency accompanied by fever in children with hematological disease and tumor, nucleic acid detection method shall be recommended for etiological diagnosis according to age, clinical characteristics and onset season, and multiple nucleic acid detection can be used for differential diagnosis. For critically ill children with acute respiratory tract infection, multiple nucleic acid detection is recommended. "